Evaluation of the effectiveness of Bamboo Salt mouthwash in the improvement of Recurrent Aphthous Ulcers

Phase 3

Recruiting

Conditions: recurrent aphthous ulcers.
Recurrent oral aphthae
K12.0

Registration Number: IRCT20160126026209N3

Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 40

Inclusion Criteria

Patients with minor aphthous lesions less than 2 days from initiation
The individuals who had not suffered from systemic diseases or immunologic disease
The patient should not receive other concurrent medication for aphthous ulcers either systematically or locally at the same time with this medicine
Patients who had a history of frequent recurrence of aphthous lesions
The occurrence of aphthous lesions is not caused by beta blockers and NSAIDs
Patients who dose not being in pregnancy or breastfeeding time
Patients who have not been receiving Anti-inflammatory or immunosuppressive drugs for at least 2 weeks before the study begins
Patients who have not been receiving systemic Antibiotics for at least 2 weeks before the study begins
Have not treated aphthous ulcers with any other medicine in the last 3 days
Patients who have not been receiving sedative medicine for other diseases

Exclusion Criteria

In case of sudden problem or violation of Inclusion criteria, the patient will be excluded from the study

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Duration of lesion's pseudomembrane removing. Timepoint: The time when the pseudomembrane and the erythematous border are removed. Method of measurement: Observing the lesion.;The size of the lesion. Timepoint: The aphthous lesion size will be recorded on days 0, 1, 3, and 5. Method of measurement: Periodontal probe.;The aphthous pain level. Timepoint: The patients are asked to record the aphthous pain level on days 0, 1, 3, and 5. Method of measurement: Visual Analogue Scale.

Secondary Outcome Measures